Organoidsciences Ltd

476040

Company Profile

  • Business description

    Organoidsciences Ltd is a three-dimensional cell structure created by self-organization. It has two products, ATORM, which is a medicine applied to various diseases and was developed using organoids derived from tissues such as intestines and salivary glands. ODISEI, an organoid-based new material evaluation solution, is an evaluation service for predicting the effects of various new materials, such as new drugs, foods, and cosmetics, when applied to the human body, and was developed using organoids for tumors, viruses, intestines, and skin.

  • Contact

    338 Pangyo-ro
    6th floor, Bundang-gu
    Gyeonggi-do
    Seongnam-si
    KOR

    T: +82 27072024

    https://organoidrx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    86

Stocks News & Analysis

stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks

Bapcor is paying for the sins of its past

Shares plunged over 17% after reporting disappointing results.
stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,393.0019.300.21%
CAC 408,206.0717.480.21%
DAX 4024,258.80427.811.80%
Dow JONES (US)46,706.58515.971.12%
FTSE 1009,403.5749.000.52%
HKSE25,858.83611.732.42%
NASDAQ22,990.54310.571.37%
Nikkei 22549,648.61463.110.94%
NZX 50 Index13,324.4820.48-0.15%
S&P 5006,735.1371.121.07%
S&P/ASX 2009,091.5015.600.17%
SSE Composite Index3,863.8924.140.63%

Market Movers